Invitae appoints technology and medtech veteran Roxi Wen as chief financial officer
SAN FRANCISCO, June 11, 2021 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of Roxi Wen as its chief financial officer, effective June 21, 2021.
- SAN FRANCISCO, June 11, 2021 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced the appointment of Roxi Wen as its chief financial officer, effective June 21, 2021.
- Wen brings decades of success as a senior financial executive where she scaled global technology and medical technology companies.
- Her track record of driving growth, financial management and execution of unique business models in the U.S. and international markets across technology and life science settings is well suited to our goals," said Sean George, Ph.D., co-founder and chief executive officer of Invitae.
- "In addition to her expertise, Roxi shares our team's passion to deliver genetic information improving healthcare for patients worldwide."